DrugCite
Search

ZALDIAR

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Zaldiar Adverse Events Reported to the FDA Over Time

How are Zaldiar adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zaldiar, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zaldiar is flagged as the suspect drug causing the adverse event.

Most Common Zaldiar Adverse Events Reported to the FDA

What are the most common Zaldiar adverse events reported to the FDA?

Vomiting
25 (2.92%)
Fall
21 (2.45%)
Drug Interaction
19 (2.22%)
Nausea
15 (1.75%)
Confusional State
13 (1.52%)
Malaise
13 (1.52%)
Somnolence
12 (1.4%)
Disorientation
11 (1.28%)
Dizziness
10 (1.17%)
Loss Of Consciousness
10 (1.17%)
Pyrexia
10 (1.17%)
Show More Show More
Abdominal Pain Upper
9 (1.05%)
Agranulocytosis
9 (1.05%)
Dyspnoea
8 (.93%)
Headache
8 (.93%)
Hyperhidrosis
8 (.93%)
Hyponatraemia
8 (.93%)
Thrombocytopenia
8 (.93%)
Vertigo
8 (.93%)
Hypertension
7 (.82%)
Hypotension
7 (.82%)
Intentional Overdose
7 (.82%)
Intraocular Pressure Increased
7 (.82%)
Amnesia
6 (.7%)
Convulsion
6 (.7%)
Drug Exposure During Pregnancy
6 (.7%)
Dyskinesia
6 (.7%)
Rectal Haemorrhage
6 (.7%)
Vision Blurred
6 (.7%)
Anaemia
5 (.58%)
Asthenia
5 (.58%)
Dehydration
5 (.58%)
Depressed Level Of Consciousness
5 (.58%)
Drug Toxicity
5 (.58%)
Foetal Growth Retardation
5 (.58%)
Hallucination
5 (.58%)
Nephritis
5 (.58%)
Pancreatitis Acute
5 (.58%)
Peripheral Coldness
5 (.58%)
Suicide Attempt
5 (.58%)
Abdominal Pain
4 (.47%)
Arthralgia
4 (.47%)
Blood Pressure Systolic Increased
4 (.47%)
Bradycardia
4 (.47%)
Cardiac Arrest
4 (.47%)
Chromaturia
4 (.47%)
Coma
4 (.47%)
Cytolytic Hepatitis
4 (.47%)
Diarrhoea
4 (.47%)
Dysuria
4 (.47%)
Epilepsy
4 (.47%)
Face Oedema
4 (.47%)
Gallbladder Pain
4 (.47%)
Haematemesis
4 (.47%)
Haemoglobin Decreased
4 (.47%)
Hemiplegia
4 (.47%)
Hypertonia
4 (.47%)
Incorrect Dose Administered
4 (.47%)
Insomnia
4 (.47%)
Leukopenia
4 (.47%)
Muscle Contractions Involuntary
4 (.47%)
Myoclonus
4 (.47%)
Overdose
4 (.47%)
Paraesthesia
4 (.47%)
Pruritus
4 (.47%)
Rash
4 (.47%)
Renal Failure Acute
4 (.47%)
Syncope
4 (.47%)
Weight Decrease Neonatal
4 (.47%)
Abnormal Behaviour
3 (.35%)
Accidental Death
3 (.35%)
Anxiety
3 (.35%)
Asthma
3 (.35%)
Blood Pressure Increased
3 (.35%)
Cerebrovascular Disorder
3 (.35%)
Cognitive Disorder
3 (.35%)
Cold Sweat
3 (.35%)
Congenital Acrochordon
3 (.35%)
Congenital Hearing Disorder
3 (.35%)
Drug Ineffective
3 (.35%)
Eosinophilia
3 (.35%)
Erythema
3 (.35%)
Gamma-glutamyltransferase Increased
3 (.35%)
Hallucination, Visual
3 (.35%)
International Normalised Ratio Incr...
3 (.35%)
Lung Disorder
3 (.35%)
Medication Error
3 (.35%)
Miosis
3 (.35%)
Muscle Spasms
3 (.35%)
Oedema
3 (.35%)
Oedema Peripheral
3 (.35%)
Photosensitivity Reaction
3 (.35%)
Pneumonia
3 (.35%)
Rash Maculo-papular
3 (.35%)
Respiratory Depression
3 (.35%)
Septic Shock
3 (.35%)
Thrombotic Thrombocytopenic Purpura
3 (.35%)
Toxic Epidermal Necrolysis
3 (.35%)
Urinary Incontinence
3 (.35%)
Urinary Tract Infection
3 (.35%)
Urticaria
3 (.35%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Zaldiar, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zaldiar is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zaldiar

What are the most common Zaldiar adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zaldiar, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zaldiar is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Zaldiar According to Those Reporting Adverse Events

Why are people taking Zaldiar, according to those reporting adverse events to the FDA?

Pain
84
Drug Use For Unknown Indication
60
Back Pain
24
Arthralgia
22
Product Used For Unknown Indication
21
Toothache
7
Show More Show More
Prophylaxis
6
Neuropathy Peripheral
6
Analgesic Therapy
5
Rheumatoid Arthritis
4
Drug Exposure During Pregnancy
4
Arthritis
4
Fibromyalgia
3
Bone Pain
3
Contusion
3
Parkinsonism
2
Muscle Spasms
2
Procedural Pain
2
Tooth Abscess
2
Hernia
2
Self-medication
2
Headache
2
Humerus Fracture
2
Spinal Compression Fracture
2
Analgesia
2
Sciatica
2
Osteoarthritis
2
Trigeminal Neuralgia
2
Ill-defined Disorder
1
Periarthritis
1
Torticollis
1
Intentional Overdose
1
Tendonitis
1
Polyarthritis
1
Cancer Pain
1
Pain In Extremity
1
Intervertebral Disc Disorder
1
Pathological Fracture
1
Dental Operation
1
Hip Arthroplasty
1
Paraesthesia
1
Spinal Cord Compression
1
Ear Pain
1
Spinal Osteoarthritis
1
Dysmenorrhoea
1
Intervertebral Disc Displacement
1
Pain Management
1
Post Herpetic Neuralgia
1
Rotator Cuff Syndrome
1
Intervertebral Disc Protrusion
1
Musculoskeletal Pain
1

Zaldiar Case Reports

What Zaldiar safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Zaldiar. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Zaldiar.